ANPC - AnPac Bio-Medical Science Co., Ltd.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
Total Revenue
11,732
10,250
5,686
Cost of Revenue
6,304
5,672
3,954
Gross Profit
5,428
4,578
1,732
Operating Expenses
Research Development
9,498
10,106
11,405
Selling General and Administrative
73,610
38,674
31,428
Total Operating Expenses
82,852
48,187
42,655
Operating Income or Loss
-77,424
-43,609
-40,923
Interest Expense
2,145
925
338
Total Other Income/Expenses Net
1,124
2,039
1,950
Income Before Tax
-78,445
-42,495
-39,311
Income Tax Expense
91
-199
9
Income from Continuing Operations
-78,536
-42,296
-39,320
Net Income
-78,342
-42,063
-39,076
Net Income available to common shareholders
-78,342
-42,063
-39,076
EBITDA
-
-38,426
-36,687